Worth stacking or unnecessary?
Retatrutide already drives significant fat loss
Tirzepatide suppresses appetite strongly alone.
AOD-9604 evidence remains pretty limited.
Mechanisms overlap somewhat, may be redundant.
Cost to benefit ratio questionable stacking
Monitor glucose closely when combining incretins.
Hunger suppression might mask excessive deficits.
More drugs doesn’t equal better outcomes.
Start single agent before layering extras.
Bloodwork and patience beat aggressive stacking.
